Noelle joined Omega Funds in October 2020. She focuses on private company investments, primarily in the fields of oncology and inflammatory disorders.
Prior to joining Omega, she led scientific strategies and vetted healthcare solutions of an emerging venture of the American Heart Association. She also worked as an independent consultant for TreMonti Consulting, where she conducted due diligence and market analyses, assessed early-stage inventions and advised clients on partnering for commercialization and in-licensing opportunities. In addition, she previously mentored entrepreneurs and startups in Science and Technology as an angel investor with Pipeline Angels.
Noelle earned her PhD in Immunology from Brown University, studying the pathobiology of acute liver injury in animal models of sepsis and septic shock. She then completed a postdoctoral fellowship in the Center for Genetics and Host Defense with a Nobel Laureate at UT Southwestern Medical Center to identify novel genes involved with mucosal immunity and gastrointestinal diseases. She also holds a BS in Biology from the University of North Carolina at Chapel Hill.
Noelle is attending / has attended:
Venture Summit Virtual Connect 21